Phreesia Falls 6.3% on Q2 Net Income Shortfall Despite 10% Revenue Growth to $129.5M
Resolved · earnings · Occurred · Assessed · 1 sources
This assessment is dated 2026-09-04. Check what remains unresolved below before relying on it.
Does the new outlook change what the company is worth?
Operating expense expansion and bottom-line earnings shortfall compress PHR's forward enterprise value-to-sales multiple despite double-digit top-line growth.
| Question | What the evidence establishes |
|---|---|
| What was reported? | Reported factPhreesia stock dropped 6.33% following its Q2 fiscal 2027 earnings release. |
| What else was confirmed? | Reported factRevenue increased 10% year-over-year to $129.5 million, beating consensus estimates. |
| Does the valuation support acting? | UnknownNo stored valuation assumptions for PHR yet — this is the next research task. |
| What would change the assessment? | UnknownPHR post-earnings analyst revisions — Consensus EBITDA and EPS estimate revisions for fiscal 2027 following the Q2 results. |
What would this event cost your holdings?
Apply your own hypothetical returns to current holding values. The calculator does not infer security effects from this event.
Test this event against my holdingsReported facts
- · Phreesia stock dropped 6.33% following its Q2 fiscal 2027 earnings release.
- · Revenue increased 10% year-over-year to $129.5 million, beating consensus estimates.
- · GAAP net income reached $1.9 million, or $0.03 per share, missing analyst expectations.
Public research record
Research framework · page evidenceCompleted event assessment
net income margin miss on healthcare SaaS valuation multiple
| Type | Claim | Scope |
|---|---|---|
| Assumption | Phreesia stock dropped 6.33% following its Q2 fiscal 2027 earnings release. | 2026-09-04 |
| Interpretation | net income margin miss on healthcare SaaS valuation multiple | PHR |
Countercase, invalidators, and sources
Operating leverage accelerates in the second half of fiscal 2027, restoring consensus profitability expectations.
- · PHR post-earnings analyst revisions — Consensus EBITDA and EPS estimate revisions for fiscal 2027 following the Q2 results.
- Why Phreesia Stock Tumbled Today · 2026-09-03
What remains unresolved
- Base path
- Revenue expands near 10% while elevated operating expenditures keep net margins muted.
- Adverse path
- Provider churn or slower payment monetization pushes operating income back toward breakeven.
- Supportive path
- Operating leverage accelerates in the second half of fiscal 2027, restoring consensus profitability expectations.
- · PHR post-earnings analyst revisions — Consensus EBITDA and EPS estimate revisions for fiscal 2027 following the Q2 results.today
Evidence
- Why Phreesia Stock Tumbled Today2026-09-03
“Phreesia (PHR) stock fell 6.33% after reporting Q2 fiscal 2027 earnings that missed analyst expectations on net income despite beating revenue estimates. While the company posted strong net income growth to $1.9 million ($0.03 per share) and 10% revenue growth to $129.5 million...”
Supports: Phreesia fell 6.33% after Q2 net income of $1.9M ($0.03 per share) missed expectations despite $129.5M revenue.